What happened?
Prenetics raised $48 million in an oversubscribed equity round to scale its IM8 supplement brand and grow a Bitcoin treasury. The deal drew a mix of traditional and crypto investors — including Kraken, Exodus and GPTX — and could bring in up to $216 million if all warrants are exercised. The company said it’s running a “1 BTC per day” plan and aims for $1 billion in annual revenue and $1 billion in Bitcoin holdings within five years.
Who does this affect?
Shareholders and anyone considering buying Prenetics stock are directly affected by the new capital, potential dilution and the company’s risky-but-ambitious strategy. Crypto investors and firms tracking Bitcoin-treasury plays will pay attention because the raise shows crossover interest from both crypto-native and traditional backers. Customers and partners of IM8 and other healthcare investors also stand to gain if the brand scales as projected and boosts recurring revenue.
Why does this matter?
This matters for the market because it highlights growing appetite for companies that combine real business growth with Bitcoin accumulation, a mix that can lift valuations but also increase volatility. Prenetics’ aggressive BTC plan and the large capital raise could pressure other Bitcoin-treasury firms, influence share premiums, and prompt responses like buybacks or new financing strategies. Overall, it signals opportunity for hybrid stories but warns investors to watch liquidity, dilution and sharp stock swings.